Enphase Energy Inc vs Personalis Inc. Common Stock — how do they compare? Enphase Energy Inc trades at $29.06 (market cap $4.23B), while Personalis Inc. Common Stock trades at $16.07 (market cap $1.69B). The key difference: Enphase Energy Inc is far larger — about 2.5× Personalis Inc. Common Stock's market cap, and Personalis Inc. Common Stock is trading nearer its 52-week high, Enphase Energy Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enphase Energy Inc for 72 Days and Personalis Inc. Common Stock for 0 Days on average.
| ENPH | PSNL | |
|---|---|---|
Market Cap | $4.23B | $1.69B |
Volume | 4,755,897 | 3,817,236 |
Sector | Energy | Health |
52-Week High | $72.33 | $18.38 |
52-Week Low | $26.12 | $5.04 |
Typical Hold Time | 72 Days | 0 Days |
Enterprise Value | $3.88B | $1.52B |
Signals from Pluang's Aura AI — not financial advice
Enphase Energy (ENPH) trades at $29.35, down 6.8% in the last session, reflecting recent volatility amid broader solar sector pressures. The stock shows a bearish technical signal with key support at $29. Valuation ratios like a P/E of 31.71 and P/S of 3.22 suggest a premium, while recent quarters saw mixed earnings with two misses. Positive developments include utility approvals for its IQ Meter Collar and advancements in solid-state transformer technology for AI data centers.
The outlook is cautious; while analyst consensus targets $43.18 implying upside, high borrowing costs and competitive risks weigh on solar stocks. Revenue declined from 2023's $2.3B to $1.47B in 2025, though net margins improved. Investors should balance growth potential in energy tech against execution risks and market sentiment shifts.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
Read more on ENPH →Personalis Inc. is a cancer genomics company that provides tumor- and blood-based DNA and RNA sequencing tests, including its NeXT Personal liquid biopsy test for cancer monitoring.
Read more on PSNL →